HPV immunisation and cervical screening—confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study

T J Palmer, M McFadden, K G J Pollock, K Kavanagh, K Cuschieri, M Cruickshank, S Cotton, S Nicoll, C Robertson

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

To document the effect of bivalent HPV immunisation on cervical cytology as a screening test and assess the implications of any change, using a retrospective analysis of routinely collected data from the Scottish Cervical Screening Programme (SCSP). Data were extracted from the Scottish Cervical Call Recall System (SCCRS), the Scottish Population Register and the Scottish Index of Multiple Deprivation. A total of 95 876 cytology records with 2226 linked histology records from women born between 1 January 1988 and 30 September 1993 were assessed. Women born in or after 1990 were eligible for the national catch-up programme of HPV immunisation. The performance of cervical cytology as a screening test was evaluated using the key performance indicators used routinely in the English and Scottish Cervical Screening Programmes (NHSCSP and SCSP), and related to vaccination status. Significant reductions in positive predictive value (16%) and abnormal predictive value (63%) for CIN2 and the mean colposcopy score (18%) were observed. A significant increase (38%) in the number of women who had to be referred to colposcopy to detect one case of CIN2 was shown. The negative predictive value of negative- or low-grade cytology for CIN2 increased significantly (12%). Sensitivity and specificity, as used by the UK cervical screening programmes, were maintained. The lower incidence of disease in vaccinated women alters the key performance indicators of cervical cytology used to monitor the quality of the screening programme. These findings have implications for screening, colposcopy referral criteria, colposcopy practice and histology reporting.
LanguageEnglish
JournalBritish Journal of Cancer
Early online date4 Feb 2016
DOIs
Publication statusE-pub ahead of print - 4 Feb 2016

Fingerprint

Immunization
Cohort Study
Colposcopy
Screening
Cell Biology
Cohort Studies
Population
Histology
Performance Indicators
Immunization Programs
Registries
Vaccination
Referral and Consultation
Sensitivity and Specificity
Specificity
Incidence
Monitor

Keywords

  • cervical cancer
  • screening
  • cervical cytology
  • HPV immunisation
  • HPV vaccination
  • colposcopy

Cite this

@article{9a15ff364ca24ebd867d8cf8d74addb4,
title = "HPV immunisation and cervical screening—confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study",
abstract = "To document the effect of bivalent HPV immunisation on cervical cytology as a screening test and assess the implications of any change, using a retrospective analysis of routinely collected data from the Scottish Cervical Screening Programme (SCSP). Data were extracted from the Scottish Cervical Call Recall System (SCCRS), the Scottish Population Register and the Scottish Index of Multiple Deprivation. A total of 95 876 cytology records with 2226 linked histology records from women born between 1 January 1988 and 30 September 1993 were assessed. Women born in or after 1990 were eligible for the national catch-up programme of HPV immunisation. The performance of cervical cytology as a screening test was evaluated using the key performance indicators used routinely in the English and Scottish Cervical Screening Programmes (NHSCSP and SCSP), and related to vaccination status. Significant reductions in positive predictive value (16{\%}) and abnormal predictive value (63{\%}) for CIN2 and the mean colposcopy score (18{\%}) were observed. A significant increase (38{\%}) in the number of women who had to be referred to colposcopy to detect one case of CIN2 was shown. The negative predictive value of negative- or low-grade cytology for CIN2 increased significantly (12{\%}). Sensitivity and specificity, as used by the UK cervical screening programmes, were maintained. The lower incidence of disease in vaccinated women alters the key performance indicators of cervical cytology used to monitor the quality of the screening programme. These findings have implications for screening, colposcopy referral criteria, colposcopy practice and histology reporting.",
keywords = "cervical cancer, screening, cervical cytology, HPV immunisation, HPV vaccination, colposcopy",
author = "Palmer, {T J} and M McFadden and Pollock, {K G J} and K Kavanagh and K Cuschieri and M Cruickshank and S Cotton and S Nicoll and C Robertson",
year = "2016",
month = "2",
day = "4",
doi = "10.1038/bjc.2015.474",
language = "English",
journal = "British Journal of Cancer",
issn = "0007-0920",

}

HPV immunisation and cervical screening—confirmation of changed performance of cytology as a screening test in immunised women : a retrospective population-based cohort study. / Palmer, T J; McFadden, M; Pollock, K G J; Kavanagh, K; Cuschieri, K; Cruickshank, M; Cotton, S; Nicoll, S; Robertson, C.

In: British Journal of Cancer, 04.02.2016.

Research output: Contribution to journalArticle

TY - JOUR

T1 - HPV immunisation and cervical screening—confirmation of changed performance of cytology as a screening test in immunised women

T2 - British Journal of Cancer

AU - Palmer, T J

AU - McFadden, M

AU - Pollock, K G J

AU - Kavanagh, K

AU - Cuschieri, K

AU - Cruickshank, M

AU - Cotton, S

AU - Nicoll, S

AU - Robertson, C

PY - 2016/2/4

Y1 - 2016/2/4

N2 - To document the effect of bivalent HPV immunisation on cervical cytology as a screening test and assess the implications of any change, using a retrospective analysis of routinely collected data from the Scottish Cervical Screening Programme (SCSP). Data were extracted from the Scottish Cervical Call Recall System (SCCRS), the Scottish Population Register and the Scottish Index of Multiple Deprivation. A total of 95 876 cytology records with 2226 linked histology records from women born between 1 January 1988 and 30 September 1993 were assessed. Women born in or after 1990 were eligible for the national catch-up programme of HPV immunisation. The performance of cervical cytology as a screening test was evaluated using the key performance indicators used routinely in the English and Scottish Cervical Screening Programmes (NHSCSP and SCSP), and related to vaccination status. Significant reductions in positive predictive value (16%) and abnormal predictive value (63%) for CIN2 and the mean colposcopy score (18%) were observed. A significant increase (38%) in the number of women who had to be referred to colposcopy to detect one case of CIN2 was shown. The negative predictive value of negative- or low-grade cytology for CIN2 increased significantly (12%). Sensitivity and specificity, as used by the UK cervical screening programmes, were maintained. The lower incidence of disease in vaccinated women alters the key performance indicators of cervical cytology used to monitor the quality of the screening programme. These findings have implications for screening, colposcopy referral criteria, colposcopy practice and histology reporting.

AB - To document the effect of bivalent HPV immunisation on cervical cytology as a screening test and assess the implications of any change, using a retrospective analysis of routinely collected data from the Scottish Cervical Screening Programme (SCSP). Data were extracted from the Scottish Cervical Call Recall System (SCCRS), the Scottish Population Register and the Scottish Index of Multiple Deprivation. A total of 95 876 cytology records with 2226 linked histology records from women born between 1 January 1988 and 30 September 1993 were assessed. Women born in or after 1990 were eligible for the national catch-up programme of HPV immunisation. The performance of cervical cytology as a screening test was evaluated using the key performance indicators used routinely in the English and Scottish Cervical Screening Programmes (NHSCSP and SCSP), and related to vaccination status. Significant reductions in positive predictive value (16%) and abnormal predictive value (63%) for CIN2 and the mean colposcopy score (18%) were observed. A significant increase (38%) in the number of women who had to be referred to colposcopy to detect one case of CIN2 was shown. The negative predictive value of negative- or low-grade cytology for CIN2 increased significantly (12%). Sensitivity and specificity, as used by the UK cervical screening programmes, were maintained. The lower incidence of disease in vaccinated women alters the key performance indicators of cervical cytology used to monitor the quality of the screening programme. These findings have implications for screening, colposcopy referral criteria, colposcopy practice and histology reporting.

KW - cervical cancer

KW - screening

KW - cervical cytology

KW - HPV immunisation

KW - HPV vaccination

KW - colposcopy

UR - http://www.nature.com/bjc/journal/vaop/ncurrent/full/bjc2015474a.html

U2 - 10.1038/bjc.2015.474

DO - 10.1038/bjc.2015.474

M3 - Article

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

ER -